Papillary microcarcinoma: Is there any difference between clinically overt and occult tumors?

World Journal of Surgery

Volumn 30, Issue 5, 2006, Pages 759-766

  Lo, Chung Yau ^a   Chan, Wai Fan ^a   Lang, Brian Hung Hin ^a   Lam, King Yin ^b   Wan, Koon Yat ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHILD; FEMALE; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; OCCULT CANCER; THYROID CARCINOMA; THYROID DISEASE; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; TREATMENT OUTCOME; TUMOR VOLUME;

ADENOCARCINOMA, PAPILLARY; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CHILD; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IODINE RADIOISOTOPES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; SURVIVAL ANALYSIS; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 33646575888     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-005-0363-8     Document Type: Article

References (27)

1. Hedinger CE, Williams ED, Sobin LH. Histological typing of thyroid tumours. In Hedinger CE, editor. International Histological Classification of Tumors, vol 11, Berlin, Springer-Verlag, 1988:7-68.
2. Ross DS. Nonpalpable thyroid nodules: managing an epidemic. J Clin Endocrinol Metab 2002;87:1938-1940.
3. Papini E, Guglielmi R, Bianchini A, et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 2002;87:1941-1946.
4. Bramley MD, Harrison BJ. Papillary microcarcinoma of the thyroid gland. Br J Surg 1996;83:1674-1683.
5. Piersanti M, Ezzat S, Asa SL. Controversies in papillary microcarcinoma of the thyroid. Endocr Pathol 2003;14:183-191.
6. Allo MD, Christiansen W, Koivunen D. Not all "occult" papillary microcarcinomas are "minimal." Surgery 1988;104:971-976.
7. Woolner LB, Lemmon ML, Beahrs OH, et al. Occult papillary thyroid carcinoma of the thyroid gland: a study of 140 cases observed in a 30 year period. J Clin Endocrinol Metab 1960;20:89-105.
8. Hay IH, Grant CS, van Heerden, et al. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 1992;112:1139-1147.
9. Wada N, Duh Q-Y, Sugino K, et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas. Frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 2003;237:399-407.
10. Sugitani I, Yanagisawa A, Shimizu A, et al. Clinicopathologic and immunohistochemical studies of papillary thyroid carcinoma presenting with cervical lymphadenopathy. World J Surg 1998;22:731-737.
11. Baudin E, Travagli JP, Ropers J, et al. Microcarcinoma of the thyroid gland. The Gustave-Roussy Institute experience. Cancer 1998;83:553-559.
12. Rodriguez JM, Moreno A, Parilla P, et al. Papillary thyroid microcarcinoma: clinical study and prognosis. Eur J Surg 1997;163:255-259.
13. Cady B, Rossi R, Silverman M, et al. Further evidence of the validity of risk group definition in differentiated thyroid carcinoma. Surgery 1985;98:1171-1178.
14. DeGroot LJ, Kaplan EL, McCormick M, et al. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endcorinol Metab 1990;71:414-424.
15. UICC (International Union Against Cancer). TNM Classification of Malignant Tumours, 5th Edition, Sobin LH, Wittekind C, editors. New York; Wiley, 1997.
16. Hay ID, Bergstralh EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993;114:1050-1058.
17. Kaplan EL, Meier P. Nonparameteric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-481.
18. Shattuck TM, Westra WH, Ladenson PW, et al. Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma. N Engl J Med 2005;352:2406-2412.
19. Pellegriti G, Scollo C, Lumera G, et al. Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. J Clin Endocrinol Metab 2004;89:3713-3720.
20. Chow SM, Law SCK, Chan JKC, et al. Papillary microcarcinoma of the thyroid prognostic significance of lymph node metastasis and multifocality. Cancer 2003;98:31-40.
21. Sampson RJ, Oka H, Key CR, et al. Metastases from occult thyroid carcinoma: an autopsy study from Hiroshima and Nagasaki Japan. Cancer 1970;25:803-811.
22. Frauenhoffer CM, Patchetsky AS, Cobanoglu A. Thyroid carcinoma, a clinical and pathologic study of 125 cases. Cancer 1979;43:2414-2421.
23. Ito Y, Uruno T, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 2003;13:381-387.
24. Ito Y, Tomoda C, Uruno T, et al. Papillary microcarcinoma of the thyroid: how should it be treated? World J Surg 2004;28:1115-1121.
25. Pearce EN, Braverman LE. Editorial: Papillary thyroid microcarcinoma outcomes and implications for treatment. J Clin Endocrinol Metab 2004;89:3710-3712.
26. Loh KC, Greenspan FS, Gee L, et al. Pathologic tumornode-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. J Clin Endocrinol Metab 1997;82:3533-3562.
27. Lo CY, Chan WF, Lam KY, Wan KY. Optimizing the treatment of AMES high risk papillary thyroid carcinoma. World J Surg 2004;28:1103-1109.